Index of artpub/2018/pmc_30585257/

Páez, David
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype
2018
https://ddd.uab.cat/record/228074
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Paez,_David2022-06-29 13:33 13  
[ ]2=Pharmacogenetic_clinical_randomised_phase...2022-06-29 13:33 214  
[ ]3=20182022-06-29 13:33 5  
[ ]4=2280742022-06-29 13:33 34  
[TXT]pmc_30585257.dirinfo2024-10-02 04:39 341  
[ ]pmc_30585257.du2024-10-02 04:39 33  
[TXT]pmc_30585257.dupdirs2024-10-02 04:39 0  
[TXT]pmc_30585257.dupfiles2024-10-02 04:39 0  
[TXT]pmc_30585257.errors2024-10-02 04:39 0  
[IMG]pmc_30585257.gif2024-10-02 04:39 39K 
[IMG]pmc_30585257.ico2024-10-02 04:39 12K 
[TXT]pmc_30585257.info2024-10-02 04:39 49K 
[TXT]pmc_30585257.md52024-10-02 04:39 51  
[ ]pmc_30585257.pdf2024-10-02 04:39 333K 
[TXT]pmc_30585257.sha12024-10-02 04:39 59  
[TXT]pmc_30585257.sha2562024-10-02 04:39 83  
[TXT]pmc_30585257.stats2024-10-02 04:39 245  
[TXT]pmc_30585257.txt2024-10-02 04:39 50K